Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

December 13, 2021 | Abstract
Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing
ASH
Read More
December 13, 2021 | Abstract
Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
ASH
Read More
December 13, 2021 | Abstract
Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma
ASH
Read More
December 13, 2021 | Abstract
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib
ASH
Read More
October 12, 2021 | Article
Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection
Med (Cell Press)
Read More
July 22, 2021 | Manuscript
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
Nature Biotechnology
Read More